Literature DB >> 9797497

The lymphocytic alveolitis in sarcoidosis is associated with increased amounts of soluble and cell-bound adhesion molecules in bronchoalveolar lavage fluid and serum.

M Berlin1, J Lundahl, C M Sköld, J Grunewald, A Eklund.   

Abstract

OBJECTIVES: Pulmonary sarcoidosis is a chronic inflammatory disorder of unknown aetiology accompanied by a lymphocytic alveolitis. It is likely that a selective and temporal expression of adhesion molecules plays a crucial role in the recruitment of cells to the inflammatory site. We investigated the expression of adhesion molecules on alveolar T-lymphocytes and in bronchoalveolar lavage (BAL) fluid and serum to elucidate mechanisms behind the accumulation of cells in the lung in sarcoidosis.
DESIGN: In a cross-sectional study in patients with active and inactive sarcoidosis and in healthy volunteers, we examined, in serum and in BAL fluid, the soluble adhesion molecules, VCAM-1, ICAM-1, and P-, E- and L-selectin. In addition, the expressions of alpha4-beta1 (VLA-4) and alpha5-beta1 (VLA-5) integrins on alveolar T-lymphocytes were analysed.
SETTING: The subjects attended the outpatient clinic at the Division of Respiratory Medicine, Karolinska Hospital, Stockholm, Sweden.
SUBJECTS: Nineteen sarcoidosis patients, nine with clinically active disease, and 13 healthy volunteers were included in the study. The sarcoidosis diagnosis was based on a typical histological and/or clinical (symptoms, radiograph, lung function) picture.
RESULTS: In sarcoidosis patients, particularly in those with active disease, an increase of the expressions of beta1-integrins was accompanied by elevated concentrations in BAL fluid of soluble VCAM-1. In serum, the levels of E-selectin and ICAM-1 were significantly higher in patients with active disease than in those with inactive disease and controls.
CONCLUSIONS: The findings offer some mechanistic explanations as to how the cell-rich alveolitis in sarcoidosis occurs, and furthermore suggest additional markers, such as s-ICAM-1, for assessment of disease activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797497     DOI: 10.1046/j.1365-2796.1998.00378.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  5 in total

1.  Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.

Authors:  J Wahlström; M Berlin; C M Sköld; H Wigzell; A Eklund; J Grunewald
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

2.  Efficient generalized least squares method for mixed population and family-based samples in genome-wide association studies.

Authors:  Jia Li; James Yang; Albert M Levin; Courtney G Montgomery; Indrani Datta; Sheri Trudeau; Indra Adrianto; Paul McKeigue; Michael C Iannuzzi; Benjamin A Rybicki
Journal:  Genet Epidemiol       Date:  2014-05-20       Impact factor: 2.135

3.  Possible role of L-selectin in T lymphocyte alveolitis in patients with active pulmonary sarcoidosis.

Authors:  M Kaseda; J Kadota; H Mukae; S Kawamoto; T Shukuwa; T Iwashita; Y Matsubara; Y Ishimatsu; M Yoshinaga; K Abe; S Kohno
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

4.  T-cell activation profiles in different granulomatous interstitial lung diseases--a role for CD8+CD28(null) cells?

Authors:  M Heron; A M E Claessen; J C Grutters; J M M van den Bosch
Journal:  Clin Exp Immunol       Date:  2009-12-17       Impact factor: 4.330

Review 5.  Integrins as Therapeutic Targets for Respiratory Diseases.

Authors:  C M Teoh; S S L Tan; T Tran
Journal:  Curr Mol Med       Date:  2015       Impact factor: 2.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.